Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Endarterectomy | 2 | 2019 | 60 | 0.89 | Why? |
| alpha 1-Antitrypsin Deficiency | 1 | 2021 | 94 | 0.80 | Why? |
| Adrenergic beta-2 Receptor Agonists | 3 | 2017 | 142 | 0.75 | Why? |
| Muscarinic Antagonists | 2 | 2017 | 176 | 0.73 | Why? |
| Tropanes | 1 | 2017 | 18 | 0.69 | Why? |
| Biological Factors | 1 | 2021 | 276 | 0.68 | Why? |
| Formoterol Fumarate | 1 | 2017 | 61 | 0.64 | Why? |
| Metabolome | 1 | 2020 | 624 | 0.59 | Why? |
| Bronchodilator Agents | 2 | 2017 | 444 | 0.56 | Why? |
| Pulmonary Artery | 2 | 2019 | 803 | 0.54 | Why? |
| Exercise Tolerance | 2 | 2019 | 634 | 0.54 | Why? |
| Pulmonary Disease, Chronic Obstructive | 7 | 2019 | 3832 | 0.47 | Why? |
| Pulmonary Fibrosis | 1 | 2021 | 1068 | 0.44 | Why? |
| Forced Expiratory Volume | 5 | 2018 | 632 | 0.36 | Why? |
| Vital Capacity | 3 | 2018 | 399 | 0.34 | Why? |
| Respiratory Function Tests | 5 | 2019 | 1755 | 0.33 | Why? |
| Asthma | 8 | 2018 | 4383 | 0.29 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.25 | Why? |
| Exercise | 4 | 2019 | 6771 | 0.24 | Why? |
| Dinoprost | 2 | 2018 | 49 | 0.23 | Why? |
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 2309 | 0.22 | Why? |
| Deoxyguanosine | 1 | 2018 | 19 | 0.19 | Why? |
| Grandparents | 1 | 2018 | 21 | 0.19 | Why? |
| Expert Systems | 1 | 2018 | 42 | 0.18 | Why? |
| Software Design | 1 | 2018 | 87 | 0.18 | Why? |
| Administration, Inhalation | 4 | 2017 | 1647 | 0.18 | Why? |
| Body Image | 1 | 2018 | 96 | 0.17 | Why? |
| Lung | 7 | 2021 | 31049 | 0.16 | Why? |
| Macrophages, Alveolar | 1 | 2020 | 668 | 0.16 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.16 | Why? |
| Leisure Activities | 1 | 2018 | 221 | 0.15 | Why? |
| Regeneration | 1 | 2019 | 429 | 0.15 | Why? |
| Pyridones | 1 | 2021 | 738 | 0.15 | Why? |
| Lung Diseases | 2 | 2019 | 2361 | 0.14 | Why? |
| Interleukin-8 | 1 | 2020 | 964 | 0.14 | Why? |
| Exercise Test | 2 | 2019 | 911 | 0.14 | Why? |
| Walking | 1 | 2019 | 442 | 0.14 | Why? |
| Dyspnea | 2 | 2018 | 3847 | 0.14 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.13 | Why? |
| Tobacco Smoking | 1 | 2018 | 349 | 0.13 | Why? |
| Awareness | 1 | 2018 | 529 | 0.13 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.13 | Why? |
| Peptide Hydrolases | 1 | 2021 | 1269 | 0.13 | Why? |
| Specialization | 1 | 2017 | 432 | 0.12 | Why? |
| Indoles | 1 | 2021 | 1243 | 0.12 | Why? |
| Respiration | 1 | 2018 | 729 | 0.12 | Why? |
| Bronchoscopy | 1 | 2020 | 991 | 0.12 | Why? |
| Quality of Life | 3 | 2017 | 9820 | 0.11 | Why? |
| Ventricular Dysfunction, Right | 1 | 2019 | 639 | 0.11 | Why? |
| Receptors, Adrenergic, beta-2 | 1 | 2011 | 32 | 0.11 | Why? |
| Rhinitis, Allergic, Seasonal | 2 | 2017 | 121 | 0.10 | Why? |
| Tertiary Care Centers | 3 | 2020 | 8248 | 0.09 | Why? |
| Vitamin D | 2 | 2020 | 2904 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.09 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 1322 | 0.09 | Why? |
| Dietary Supplements | 1 | 2020 | 2251 | 0.08 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.08 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.08 | Why? |
| Precision Medicine | 1 | 2017 | 1477 | 0.08 | Why? |
| Vitamin D Deficiency | 1 | 2020 | 1782 | 0.08 | Why? |
| Severity of Illness Index | 6 | 2021 | 48226 | 0.08 | Why? |
| Italy | 9 | 2020 | 38444 | 0.08 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.07 | Why? |
| Parents | 1 | 2018 | 2758 | 0.07 | Why? |
| Hypertension, Pulmonary | 1 | 2014 | 970 | 0.07 | Why? |
| Spirometry | 2 | 2018 | 524 | 0.07 | Why? |
| Adrenal Cortex Hormones | 2 | 2020 | 6537 | 0.07 | Why? |
| Europe | 5 | 2018 | 12702 | 0.07 | Why? |
| Humans | 29 | 2021 | 930598 | 0.07 | Why? |
| Rhinitis, Allergic, Perennial | 1 | 2003 | 36 | 0.06 | Why? |
| Glucocorticoids | 2 | 2017 | 4431 | 0.06 | Why? |
| Middle Aged | 17 | 2020 | 270681 | 0.06 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.06 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.06 | Why? |
| Aged | 14 | 2020 | 215776 | 0.06 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.06 | Why? |
| Male | 20 | 2020 | 367725 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Health Surveys | 3 | 2018 | 2841 | 0.06 | Why? |
| Female | 20 | 2020 | 380317 | 0.06 | Why? |
| Practice Patterns, Physicians' | 2 | 2017 | 4927 | 0.06 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.05 | Why? |
| Sitagliptin Phosphate | 1 | 2020 | 82 | 0.05 | Why? |
| Adult | 14 | 2020 | 244371 | 0.05 | Why? |
| Whey Proteins | 1 | 2020 | 59 | 0.05 | Why? |
| Regression Analysis | 2 | 2018 | 2484 | 0.05 | Why? |
| Australia | 3 | 2018 | 6306 | 0.05 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2018 | 5002 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.05 | Why? |
| Drug Combinations | 2 | 2020 | 3852 | 0.05 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.05 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2020 | 88759 | 0.05 | Why? |
| Illness Behavior | 1 | 2018 | 76 | 0.05 | Why? |
| Multilevel Analysis | 1 | 2018 | 104 | 0.05 | Why? |
| Microscopy, Electron, Transmission | 1 | 2020 | 605 | 0.05 | Why? |
| Surveys and Questionnaires | 4 | 2018 | 43792 | 0.05 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Body Height | 1 | 2018 | 100 | 0.04 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2011 | 3607 | 0.04 | Why? |
| Regenerative Medicine | 1 | 2019 | 161 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2020 | 961 | 0.04 | Why? |
| Bronchoalveolar Lavage | 1 | 2020 | 603 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Sample Size | 1 | 2018 | 518 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.03 | Why? |
| Breath Tests | 1 | 2018 | 338 | 0.03 | Why? |
| Prenatal Exposure Delayed Effects | 1 | 2018 | 319 | 0.03 | Why? |
| Exhalation | 1 | 2018 | 441 | 0.03 | Why? |
| Interleukin-10 | 1 | 2020 | 1409 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.03 | Why? |
| Respiration Disorders | 1 | 2018 | 526 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.03 | Why? |
| Lung Compliance | 1 | 2014 | 243 | 0.03 | Why? |
| Extracellular Vesicles | 1 | 2019 | 607 | 0.03 | Why? |
| Virion | 1 | 2020 | 1444 | 0.03 | Why? |
| Anti-Asthmatic Agents | 1 | 2017 | 427 | 0.03 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.03 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.03 | Why? |
| Bronchial Hyperreactivity | 1 | 2011 | 38 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Withholding Treatment | 1 | 2017 | 798 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2020 | 2115 | 0.03 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.03 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.03 | Why? |
| Malnutrition | 1 | 2020 | 932 | 0.03 | Why? |
| Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.03 | Why? |
| Homozygote | 1 | 2011 | 230 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| Activities of Daily Living | 1 | 2018 | 1530 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.02 | Why? |
| Delayed-Action Preparations | 1 | 2011 | 291 | 0.02 | Why? |
| Patient Compliance | 1 | 2018 | 1468 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Cost of Illness | 1 | 2018 | 1903 | 0.02 | Why? |
| Lymphocytes | 1 | 2020 | 3056 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| Pilot Projects | 1 | 2018 | 5182 | 0.02 | Why? |
| Electrocardiography | 1 | 2020 | 3957 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Self Report | 1 | 2018 | 3802 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Hemodynamics | 1 | 2014 | 1562 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Alleles | 1 | 2011 | 1557 | 0.02 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.02 | Why? |
| Guideline Adherence | 1 | 2017 | 2309 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Cough | 1 | 2018 | 4891 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2014 | 5440 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.01 | Why? |
| Genotype | 1 | 2011 | 4697 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Models, Statistical | 1 | 2014 | 5312 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Infant | 1 | 2018 | 30274 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Animals | 1 | 2019 | 78931 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
Corsico's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(222)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_